Pfizer/BioNTech COVID-19 vaccine safe, effective in 12 to 15 year olds, say companies |
Clinical News
eMediNexus Coverage from: 
Pfizer/BioNTech COVID-19 vaccine safe, effective in 12 to 15 year olds, say companies

0 Read Comments                

According to Pfizer Inc and BioNTech SE, their vaccine against COVID-19 was safe and effective and evoked strong antibody responses in children aged 12 to 15 years.

The vaccine is currently authorized for use in those aged 16 and above. A new study provides evidence that the vaccine will work in school-age adolescents as well. The study included 2,260 children, 12 to 15 years of age and noted 18 cases of COVID-19 in the group that received a placebo shot and no cases in those who received the vaccine, translating to a 100% efficacy in preventing COVID-19, reported the companies in a statement. Pfizer plans to seek emergency use authorization from the U.S. Food and Drug Administration as well as other regulators globally in the weeks to come… (ET Healthworld – Reuters, April 1, 2021)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now